Surrogates Endpoint: Is it Sufficient to Support Approval and Clinical Use of Cerebral Embolic Protection Devices - Michael Mack, MD

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Surrogates Endpoint: Is it Sufficient to Support Approval and Clinical Use of Cerebral Embolic Protection Devices presented by Michael Mack, MD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists 
  • Structural Heart Specialists 
  • Interventional Fellows 
  • Cardiac Surgeons 

Session Name: Percutaneous Aortic Valves: Knowledge Gaps in a Maturing Technology

Track: Track: CRT Valve & Structural

Learning Objectives

  • Update in advances/best practice in Valve & Structural procedures
Loading Simple Education